Clinical Trials Browser

Neoplasms × pemigatinib × Clear all

NCT02925234 2024-01-24

DRUP

Phase 2 Recruiting

Neoplasms

NCT03235570 2020-05-29

A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)

Phase 1 Completed

Acrocephalosyndactylia, Neoplasms